A trial of dobutamine infusion up to 20 μg/kg per minute is recommended (in addition to a vasopressor if in use) in the presence of (a) myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output, or (b) ongoing signs of hypoperfusion, despite achievement of adequate intravascular volume and adequate MAp (grade 1C)